Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 4

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 4
---
 | 44 |
| DELIVERY OF PROXY MATERIALS TO HOUSEHOLDS                                                            |     | 45 |
| NOTICE TO SHAREHOLDERS IN THE UNITED STATES                                                          |     | 45 |
| SOLICITATION OF PROXIES                                                                              |     | 45 |
| APPROVAL OF MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT                                            |     | 45 |
| EXHIBIT A CORPORATE GOVERNANCE GUIDELINES                                                            |     | 46 |

i

TABLE OF CONTENTS

QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND VOTING What is the purpose of this Proxy Statement/Circular and the 2024 Annual Report to Shareholders? Our Board is soliciting your proxy to vote at the Annual Meeting, which will be held solely by means of live audio webcast online at www.virtualshareholdermeeting.com/ABUS2025, on Wednesday, May 21, 2025, at 10:00 a.m. (Eastern Daylight Time). This Proxy Statement/Circular contains important information about the matters to be voted on at the Annual Meeting, the voting process, the compensation of our directors and certain of our executive officers, corporate governance matters, and certain other required information. Our 2024 Annual Report to Shareholders, which consists of our Annual Report on Form 10-K for the year ended December 31, 2024 (the “Annual Report”), contains information about our business, our audited financial statements and other important information that we are required to disclose under the SEC’s rules. As many of our Shareholders may be unable to virtually attend the Annual Meeting, proxies are solicited to give each Shareholder an opportunity to vote on all matters that will properly come before the Annual Meeting. References in this Proxy Statement/Circular to the Annual Meeting include any adjournments or postponements of the Annual Meeting. How can I access the proxy materials for the Annual Meeting? Shareholders may access the proxy materials, which include the Notice, the Proxy Statement/Circular (including a form of proxy card) and our Annual Report, on our website, www.arbutusbio.com, the SEC’s website at www.sec.gov and under our profile at www.sedarplus.ca. Alternatively, Shareholders may request to receive a printed set of the proxy materials. Instructions on how to request a printed copy may be found in the Notice. In addition, Shareholders may request to receive proxy materials in printed form by mail or electronically by email on an ongoing